The George Washington University Cancer Center (site 212) is a clinical research site located in Washington D.C., District of Columbia, United States 20037.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
The George Washington University Cancer Center (site 212) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer.
Sponsors: VM Oncology, LLC.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The George Washington University Cancer Center (site 212) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The George Washington University Cancer Center (site 212) has 1 clinical trials on record, with 1 currently active. Their work covers Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer.
The George Washington University Cancer Center (site 212) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.